Lawmakers Cite Own Experiences in Grilling Drug Executives on Prices By Ricardo Alonso-Zaldivar and Matthew Perrone | March 1, 2019 Email This Subscribe to Newsletter Email to a friend Facebook Tweet LinkedIn Print Article Article 2 Comments March 1, 2019 at 11:44 am KP says: Like or Dislike: 5 0Greed. Explain to me why these same drugs from these same companies are available overseas at a much cheaper rate? Reply March 2, 2019 at 11:02 am PolarBeaRepeal says: Like or Dislike: 0 0Subsidies. Lesser controls over quality & safety. Overseas versions are NOT always the same chem composition, and patients were harmed in a few instances. Reply Add a Comment Cancel reply Your email address will not be published. Required fields are marked * Name * Email * Comment ΔNotify me of comments via e-mail
Greed.
Explain to me why these same drugs from these same companies are available overseas at a much cheaper rate?
Subsidies. Lesser controls over quality & safety. Overseas versions are NOT always the same chem composition, and patients were harmed in a few instances.